product summary
Loading...
company name :
MyBioSource
product type :
antibody
product name :
Rabbit A' Fish Collagen Type I
catalog :
MBS316323
quantity :
0.5 mL
price :
915 USD
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
more info or order :
product information
catalog number :
MBS316323
products type :
Antibody
products full name :
Rabbit A' Fish Collagen Type I
products short name :
Collagen Type I
products name syn :
Rabbit Antibody to Fish Collagen Type I
other names :
collagen, type I, alpha 1, isoform CRA_a; Collagen alpha-1(I) chain; collagen alpha-1(I) chain; collagen alpha-1(I) chain; OTTHUMP00000192905; alpha-1 type I collagen; pro-alpha-1 collagen type 1; collagen alpha 1 chain type I; collagen of skin, tendon and bone, alpha-1 chain; collagen, type I, alpha 1; Alpha-1 type I collagen
other gene names :
COL1A1; COL1A1; OI4
uniprot entry name :
CO1A1_HUMAN
clonality :
Polyclonal
host :
Rabbit
reactivity :
Fish
specificity :
Collagen Type I. Crossreactivity: (OD at a 1:100 ELISA dilution) Salmon Fish Collagen Type I - 1.0 Sole and Tuna fish Collagen Type I - Goldfish Collagen Type I - Mammalian, avian Collagen Type I - (*OD?0.2 means negative reac
purity :
Ion exchange chromatography
form :
Purified, Lyophilized. Reconstitute with 0.5ml deionized water.
storage stability :
Lyophilized: Short-term (up to 24 months) store at 2 to 8 degree C. Long term store at -20 degree C. Reconstituted: Aliquot and store (up to 6 months) at -20 degree C. Avoid multiple freeze/thaw cycles.
other info1 :
Immunogen: Collagen Type I extracted and purified from salmon fish skin
other info2 :
Buffer: Not applicable. Preservative: No. Lyophilized: Yes. Important Note: Centrifuge before opening to ensure complete recovery of vial contents.
products categories :
Polyclonal Antibodies to Collagens and Extracellular Matrix Proteins
ncbi gi num :
119615037
uniprot acc num :
P02452
ncbi mol weight :
138,941 Da
ncbi pathways :
Amoebiasis Pathway (167324); Amoebiasis Pathway (167191); Axon Guidance Pathway (105688); Cell Surface Interactions At The Vascular Wall Pathway (106062); Collagen Adhesion Via GPVI Pathway (161058); Collagen Adhesion Via Gp IV Pathway (106032); Collagen Adhesion Via Alpha 2 Beta 1 Glycoprotein Pathway (106031); ECM-receptor Interaction Pathway (83068); ECM-receptor Interaction Pathway (479); Focal Adhesion Pathway (198795)
ncbi summary :
This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish]
uniprot summary :
Function: Type I collagen is a member of group I collagen (fibrillar forming collagen). Subunit structure: Trimers of one alpha 2(I) and two alpha 1(I) chains. Interacts with MRC2. By similarity. Interacts with TRAM2. Ref.33. Subcellular location: Secreted extracellular space extracellular matrix. Tissue specificity: Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite. Post-translational modification: Proline residues at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. Proline residues at the second position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some of the chains.O-linked glycan consists of a Glc-Gal disaccharide bound to the oxygen atom of a post-translationally added hydroxyl group. Involvement in disease: Defects in COL1A1 are the cause of Caffey disease (CAFFD) [. MIM:114000]; also known as infantile cortical hyperostosis. Caffey disease is characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age. Ref.89 Ref.90 Ref.91Defects in COL1A1 are a cause of Ehlers-Danlos syndrome type 1 (EDS1) [. MIM:130000]; also known as Ehlers-Danlos syndrome gravis. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS1 is the severe form of classic Ehlers-Danlos syndrome. Ref.88 Ref.89 Ref.90 Ref.97Defects in COL1A1 are the cause of Ehlers-Danlos syndrome type 7A (EDS7A) [. MIM:130060]; also known as autosomal dominant Ehlers-Danlos syndrome type VII. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS7A is marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. Ref.89 Ref.90Defects in COL1A1 are a cause of osteogenesis imperfecta type 1 (OI1) [. MIM:166200]. A dominantly inherited connective tissue disorder characterized by bone fragility and blue sclerae. Osteogenesis imperfecta type 1 is non-deforming with normal height or mild short stature, and no dentinogenesis imperfecta. Ref.38 Ref.44 Ref.55 Ref.59 Ref.62 Ref.68 Ref.89 Ref.90 Ref.93 Ref.94 Ref.96 Ref.99 Ref.101Defects in COL1A1 are a cause of osteogenesis imperfecta type 2A (OI2A) [. MIM:166210]; also known as osteogenesis imperfecta congenita. A connective tissue disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency.Defects in COL1A1 are a cause of osteogenesis imperfecta type 3 (OI3) [. MIM:259420]. A connective tissue disorder characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfecta.Defects in COL1A1 are a cause of osteogenesis imperfecta type 4 (OI4) [. MIM:166220]; also known as osteogenesis imperfecta with normal sclerae. A connective tissue disorder characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta.Genetic variations in COL1A1 are a cause of susceptibility to osteoporosis (OSTEOP) [. MIM:166710]; also known as involutional or senile osteoporosis or postmenopausal osteoporosis. Osteoporosis is characterized by reduced bone mass, disruption of bone microarchitecture without alteration in the composition of bone. Osteoporotic bones are more at risk of fracture. Ref.81 Ref.86 Ref.89 Ref.90Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF. Ref.89 Ref.90. Sequence similarities: Belongs to the fibrillar collagen family.Contains 1 fibrillar collagen NC1 domain.Contains 1 VWFC domain. Sequence caution: The sequence BAD92834.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened.
size1 :
0.5 mL
price1 :
915 USD
more info or order :
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!